Life Science Companies Worldwide
Location
Category
List of Life Science companies in All locations
545 companies
Sort by
We are dedicated to restoring plant health and resilience by fundamentally rewriting the next 100 years of farming. Our core focus is on developing innovative solutions that address critical challenges in crop production, including disease resistance, nutrient utilization, and overall plant vigor.
Oerth Bio leverages cutting-edge PROTAC (PROteolysis Targeting Chimeras) technology to precisely control plant protein activity, offering a novel approach to sustainable agriculture and improved yields. We serve agricultural researchers and companies seeking to enhance crop performance and reduce reliance on traditional chemical inputs.
Founded in 2019, Oerth Bio currently employs 14 individuals and is rapidly expanding its research capabilities. We are committed to advancing the field of plant biotechnology and contributing to a more sustainable and productive food system.
As a subsidiary of Seegene Inc., we develop and distribute high-multiplex real-time PCR assays, empowering laboratories with cutting-edge technology for improved diagnostic workflows. Our solutions are crucial for hospitals, research institutions, and clinical laboratories seeking reliable results in a timely manner.
We provide comprehensive molecular diagnostic solutions, including COVID-19 testing, utilizing automation and advanced PCR techniques. Seegene USA supports the healthcare industry with innovative tools for disease management and public health initiatives. We are committed to advancing molecular diagnostics and improving patient outcomes through precision and speed.
We connect clinicians, therapeutic area subject matter experts, and biopharmaceutical organizations to accelerate the development of innovative treatments.
Stryde Research streamlines clinical trial processes, ensuring efficiency and quality while prioritizing patient well-being. We focus on bringing these opportunities to your community through your existing physicians, ensuring your safety and comfort.
Founded in 2021 and employing 22 people, Stryde Research is dedicated to transforming the clinical research landscape and improving patient outcomes.
We are focused on developing first-of-its-kind cell-free wound care therapeutics, harnessing the power of cell-derived molecules and nano vesicles from immunologically privileged tissues.
Our approach leverages the barrier properties of human amniotic membranes to protect soft tissues, offering innovative solutions for ophthalmology and advanced wound care. Driven by a science-led and patient-focused vision, Merakris is committed to innovation, integrity, and collaboration to transform patient lives.
Founded in 2016, Merakris has secured FDA clearance and is advancing its investigational drug development program with a strong leadership team.
We’re revolutionizing how valuable chemicals and products are made, moving beyond the limitations of traditional fermentation. Our core technology – cell-free biobased products and platforms – allows us to produce high-value compounds for agriculture, nutrition, and beyond, dramatically improving production economics and reducing environmental impact.
Zymtronix is dedicated to unlocking the full potential of enzyme systems, creating a future where biomanufacturing is more efficient, cost-effective, and sustainable. We offer end-to-end process development, combining enzyme system design with scalable production, enabling our customers to accelerate product development and unlock new opportunities.
Founded in 2013, Zymtronix employs approximately 20 people and is committed to driving innovation in the field of industrial biomanufacturing.
We provide a comprehensive portfolio of products, including biostimulants and solutions for biotic and abiotic stress, designed to enhance yields, improve nutrient use efficiency, and bolster plant innate immunity.
Plant Response leverages scientific research and field trials to deliver advanced crop nutrition to growers globally, contributing to sustainable agriculture practices and helping the world grow the food it needs. Our commitment to innovation and a science-backed approach makes us a trusted partner for agricultural professionals.
Founded in 2008, Plant Response has grown to a team of 6, with locations in the US and Spain, and continues to expand its reach and impact within the agricultural sector.
We empower scientists with the Ramona platform, a revolutionary multi-camera array microscope (MCAM) that dramatically expands field-of-view without compromising resolution. This allows researchers to capture dynamic biological systems synchronously, observing cellular-level processes as they move across space and time – a capability previously unavailable.
Ramona’s innovative technology addresses the critical need for comprehensive, real-time analysis in complex biological studies, accelerating discoveries in areas such as cell biology, developmental biology, and drug discovery. Our solutions are designed for laboratories seeking to push the boundaries of microscopy and gain deeper insights into cellular mechanisms.
Founded in 2017, Ramona Optics has quickly established itself as a leader in advanced microscopy, driven by a team of dedicated scientists and engineers. We are committed to providing cutting-edge tools that transform biological research.
We support manufacturers throughout the product lifecycle, from initial development to commercialization, offering a comprehensive suite of services including microbiology testing, sterility testing, stability studies, and analytical chemistry.
LexaMed distinguishes itself through its two-century legacy of pharmaceutical and medical device expertise, combined with ISO 13485 and ISO 17025 certifications, a State of Ohio drug license, and DEA registration. Our dedicated team provides rapid, accurate results and expert consulting to ensure your products meet the highest regulatory standards.
We are committed to exceeding customer expectations and driving innovation within the industry, offering a reliable partner for all your testing and validation needs.
We provide a comprehensive platform leveraging PCR and DNA sequencing interpretations to deliver actionable insights for healthcare providers. Our technology analyzes source of specimen, diagnosis, organisms, resistance genes, allergies, age, and gender, offering the most detailed and advanced antimicrobial stewardship program available.
Arkstone’s solutions are designed to combat the growing threat of antimicrobial resistance, empowering clinicians and laboratories with the data they need to make informed decisions and optimize patient care. We serve hospitals, reference laboratories, and diagnostic centers seeking to improve antibiotic utilization and patient outcomes.
Founded in 2018, Arkstone has rapidly grown to a team of 36 professionals, headquartered in Durham, North Carolina, with a secondary location in Cedarhurst, NY.
We empower researchers worldwide with cutting-edge technologies, including the CUTANA™ assay platform, CUT&RUN and CUT&Tag assays, and comprehensive bioinformatics solutions. EpiCypher’s renowned chromatin researchers bring unique expertise to accelerate discoveries in drug discovery and beyond.
Driven by a commitment to scientific advancement and collaboration, EpiCypher provides a suite of services, including custom nucleosome development and epigenetic profiling, alongside high-quality reagents and kits. We are dedicated to leading the epigenetics field and improving human life through innovative research solutions.
MedCure’s mission is to transform personal loss into life-giving change, fueling medical breakthroughs and training the next generation of surgeons. We partner with leading oversight organizations and offer 24/7 support to families, ensuring transparency and respect throughout the entire process.
Since 2005, MedCure has been a trusted leader in whole body donation, operating four facilities across the United States and connecting donors with research and training programs nationwide. We are committed to honoring the final wishes of donors and supporting the advancement of medical knowledge.
Established in 1994, we’ve grown with a focus on product development, innovative research, consistent quality control, and the acquisition of innovative companies in the sector.
Today, as Vitrolife Group, we’re dedicated to supporting our clients and patients worldwide to improve treatment outcomes – always with sustainability in mind. We provide products and services for the entire fertility journey, offering consistent performance and guaranteed quality.
Currently, we have approximately 1,100 people globally, headquartered in Gothenburg, Sweden, and operating in over 125 countries through a vast distribution network.
We specialize in delivering significantly higher yields of cfDNA, cfRNA, and CTCs – often exceeding those of existing systems – through our proprietary Revolution Sample Prep Platform.
nRichDX solves a critical challenge in precision medicine: inaccurate diagnostic results due to insufficient target material in liquid biopsies. Our innovative, semi-automated system, combined with the Hamilton Microlab STAR liquid handler, provides scalable, automated solutions for enhanced test sensitivity and reliability.
We are a trusted partner to leading research institutions and diagnostic labs, including Johns Hopkins University and Dartmouth, and are committed to advancing the field of liquid biopsy through continuous innovation and rigorous validation.
We are dedicated to maximizing health span and minimizing disease through the advancement of transformative medicine. Our innovative approach focuses on IMM01-STEM, a clinically advanced, first-in-class secretome product, targeting the underlying factors of aging that drive muscle and metabolic disease.
Immunis leverages the power of secretomes – the total set of factors secreted by cells – to deliver a multi-active therapeutic that simultaneously decreases fat and enhances muscle, offering a novel solution for conditions like sarcopenia, osteoarthritis, and obesity.
Recent recognition includes being named one of the "Top 50 Healthcare Technology Companies of 2025" by The Healthcare Technology Report.
We provide physics- and AI-based software solutions and services to biotech and pharmaceutical partners, enabling faster and smarter R&D. Our core offering, the RiDYMO discovery platform, integrates molecular design, computational modeling, and experimental feedback to tackle challenging drug targets.
Atombeat helps companies across diverse therapeutic modalities – including oncology, immunology, and neuroscience – to identify and optimize promising drug candidates more efficiently. We combine deep scientific expertise with cutting-edge technology to drive innovation and bring transformative therapies to patients faster.
Founded in 2023, Atombeat Inc. currently employs 8 people and is headquartered in Jersey City, New Jersey.
We specialize in developing innovative liquid biopsy solutions, leveraging our proprietary ExpressCT™ technology and GenomicsNext™ platform.
GenomicsNext™ delivers a comprehensive, single-sample readout of both DNA alterations and inferred gene expression, providing a more complete picture of the tumor’s ‘on state’ and enhancing biomarker discovery and therapy selection.
GeneCentric partners with biopharma, diagnostic developers, and researchers to enable expression-driven companion diagnostics and advance the next generation of precision medicine.
We’re evolving the future of personal care, food & beverage, and beyond by harnessing the power of nature’s building blocks – enzymes – to displace legacy petrochemicals. Our flagship products, including Curamina, Curabind, AmpliPQ™, and Evogard™, offer a clean-label, high-performance alternative for product formulators.
Founded in 2017 by a team of scientists from Fortune 500 companies, Curie Co is driven by a commitment to sustainability and innovation. We partner with leading brands to deliver future-proof ingredients that are gentle on people and the planet.
Our approach centers on optimizing naturally-occurring enzymes for superior efficiency and biodegradability, providing a truly sustainable solution for a wide range of applications.
Phronetik’s core mission is to unlock new genomic insights, enabling faster and more effective treatment discovery. We specialize in areas such as Oncology, Rare & Complex Disease, Pharmacogenomics, Infectious Disease, and Agrigenomics, providing comprehensive solutions for researchers and healthcare providers.
Through our iConcordia® platform and iHarmony-Seq™ technology, we empower our partners with the tools they need to accelerate drug development, improve patient outcomes, and advance public health initiatives. We are proud to be a key contributor to the future of precision medicine, driving transformative change across the life science and government sectors.
We’re revolutionizing soybean, corn, and other key crops by combining cutting-edge bioinformatics, genome editing, and trait validation techniques. Our mission is to compress innovation timelines and address critical challenges in agriculture, including climate change and emerging pests.
By integrating New Breeding Technologies and a technology-agnostic approach, we streamline target discovery and expedite trait development, ultimately changing the status quo in crop genetics. We are focused on developing value-added crop products through an integrated and efficient pipeline, ensuring resilience and enhanced yield.
The Traits Company is a rapidly growing company with 26 employees, headquartered at 104 TW Alexander Dr, Bldg. 1, Research Triangle Park, NC 27713 USA.
We specialize in identifying elusive infections like Bartonella, Babesia, and Borrelia – pathogens often missed by conventional diagnostics.
Galaxy Diagnostics combines direct and indirect detection methods, including Nanotrap® Urine Antigen Testing and Digital PCR, backed by over 450 peer-reviewed studies, to deliver highly sensitive and actionable results.
Our commitment to scientific rigor and clinical relevance empowers providers to confidently diagnose and treat patients with stealth pathogens, ultimately improving patient outcomes. We are trusted by leading functional and integrative providers nationwide.
We develop a novel technology platform that empowers resilient agriculture for a rapidly changing world. Our innovative approach utilizes RNA to endow crops with desired traits without altering the plant genome, offering unparalleled flexibility, precision, and speed of application throughout a plant’s lifecycle.
Terrana’s solutions are designed for growers seeking to enhance crop yields, improve plant health, and adapt to evolving environmental conditions. We are focused on delivering sustainable and impactful advancements in the agricultural sector, contributing to a more abundant and secure food supply.
Founded in 2021 and currently employing 62 people, Terrana Biosciences is rapidly establishing itself as a leader in agricultural biotechnology, with a growing presence in both Cambridge, Massachusetts and Durham, North Carolina.
We focus on addressing this devastating rare disease, which causes severe, unrelenting pain following trauma, significantly impacting patients’ quality of life and independence.
Our lead investigational program, CRPS-RISE, represents a first-in-class approach utilizing neridronate, a differentiated bisphosphonate, and is currently in a Phase 3 pivotal trial. We are pursuing Breakthrough Therapy, Fast Track, and Orphan Drug designations, reflecting the significant unmet need in this patient population.
Ambros Therapeutics is committed to translating patient experiences into impactful solutions, guided by integrity and scientific rigor.
We specialize in developing innovative, autologous cell therapies – utilizing our unique stem cell expertise and directed differentiation – to create personalized vaccines targeting both infectious diseases and cancer. Our approach, known as the ‘Clean Super Vaccine,’ uniquely addresses cancer’s ability to mutate by targeting all neoantigens, ensuring long-lasting protection.
Leveraging our proprietary platform, AIVITA Biomedical is dedicated to transforming therapeutic vision into reality, delivering safe, efficient, and economical treatments to patients in need. We are pioneering a new era of adaptive immunity against emerging pathogens and providing cutting-edge skincare solutions through strategic partnerships.
We specialize in reimagining bioprocessing through our IsoTag™ Reagent Technology, combining affinity ligands with phase separation to deliver exceptional results.
Our approach offers a chromatography-free solution, enabling rapid processing, high purity, and consolidation of unit operations – accelerating your clinical development and improving the manufacturability of advanced therapeutics.
As part of Donaldson Company, Inc., we leverage decades of filtration expertise to drive innovation in life sciences and bioprocessing, increasing global access to life-changing medicines.
We empower medical providers with targeted biomarker & diagnostic decisions, supporting precision medicine initiatives.
AdvanBio distinguishes itself through a commitment to innovation, leveraging cutting-edge technology and a deep understanding of biological materials to facilitate breakthroughs in molecular diagnostics. As a subsidiary of Autobio Diagnostics, we combine global expertise with a localized approach to meet the evolving needs of the healthcare community.
Established in 2021, AdvanBio is dedicated to the advancement of medical laboratory technology and the promotion of human health.
We empower physicians and hospitals with cutting-edge testing services, including the unique Protean MAPS® system, Follow It liquid biopsy testing, and URO17 Urine Test for bladder cancer.
Our integrated approach combines advanced genomic profiling, biomarker analysis, and data interpretation to provide actionable insights for oncologists, supporting informed treatment decisions and ultimately improving patient outcomes. We are committed to transforming innovation into action, delivering rapid results and precision oncology guidance for all cancer types.
Protean BioDiagnostics offers comprehensive testing solutions, including clinical trial participation and laboratory licensing opportunities, furthering our mission to advance cancer care through scientific discovery and technological advancement.
At ScitoVation, we leverage cutting-edge technologies like PBPK modeling, genetic data analysis, and in vitro to in vivo extrapolation (IVIVE) to bridge the gap between laboratory studies and human health. Our team of experienced scientists utilizes metabolic and pharmacokinetic expertise to understand compound behavior within the body, facilitating informed decision-making throughout the product development lifecycle.
As a recognized leader in new approach methods (NAMs), ScitoVation helps clients determine lead compound selection, understand mode of action, and screen for potential hazards. We are committed to providing practical, cost-effective solutions that accelerate research and development, ultimately contributing to safer and more effective products for consumers. PBPK modeling, toxicogenomic studies, and IVIVE are at the core of our approach.
We support companies navigating the FDA and EU MDR markets, providing critical testing to ensure patient safety and regulatory compliance. Our core service is delivering fast, accurate, and cost-effective testing solutions, including Biological Evaluation Plans, Chemical Characterization, and Toxicological Risk Assessments.
As a GLP-certified and ISO 17025-accredited laboratory, NABI offers a wide range of tests – from cytotoxicity and sensitization to hemocompatibility and genotoxicity – alongside expert regulatory consulting. We are dedicated to supporting your medical device journey from test selection to final reporting.
We pride ourselves on our commitment to quality, speed, and expert support, helping you bring safe and effective devices to patients worldwide.
We create thermostable formulations that eliminate or reduce the need for cold chain storage, simplifying manufacturing, streamlining delivery, and enabling flexible administration through multiple routes without compromising efficacy.
Founded in 2019, Jurata’s journey began with a critical need to address the Ebola outbreak in West Africa, leading to the development of a novel film that offered 100% survival in non-human primates. Today, our technology is poised to transform distribution and administration of life-saving treatments globally, offering a more accessible and resilient solution for vaccines and therapeutics.
Jurata’s team combines expertise in drug development, formulation, and manufacturing, collaborating effectively with drug developers to transform complex biologic formulation challenges into new opportunities.
Our products are designed to serve researchers in a wide range of fields, including cell biology, microbiology, hematology, immunology, and vascular permeability. We empower scientists to accelerate drug discovery and gain deeper insights into novel biological processes.
What sets BioFlux & IonFlux apart is our commitment to precision and automation, combined with a focus on user-friendly design. Founded in 2005, we’ve grown to support hundreds of labs globally, providing reliable tools and expert support. We are part of the Cell Microsystems family.
For over 30 years, BW Fusion has leveraged cutting-edge research and development to create proprietary microbial teams that deliver targeted nutrition directly to the plant. Our approach focuses on understanding the specific needs of the soil and crop, utilizing data-driven insights to formulate customized solutions.
BW Fusion distinguishes itself through a farmer-focused philosophy, prioritizing long-term partnerships and providing comprehensive support through a team of experienced agronomists and a robust dealer network. We are committed to transparency, integrity, and continuous improvement, ensuring our customers receive the most effective and sustainable crop nutrition strategies.
We focus on developing innovative solutions for neurological disorders, particularly those related to pain and inflammation. Our team leverages cutting-edge research in neuroscience and drug discovery to identify and advance promising drug candidates.
Somanta Pharmaceuticals is dedicated to translating scientific breakthroughs into effective treatments for patients in need. We operate within the **biotechnology research** sector, employing a highly skilled team of scientists and researchers committed to improving patient outcomes. Our approach centers on precision medicine and targeted therapies, aiming to address the underlying causes of neurological conditions.
We are committed to advancing the field of neuroscience and delivering impactful therapies to those who need them most.
Our mission is to unite together for a safer, healthier future by fostering a collaborative ecosystem of researchers, entrepreneurs, and investors.
I-CREATE offers a 12-week program with the potential to win up to $50,000 in funding, connecting innovators with crucial resources and expertise to bring their medical device and diagnostic solutions to market. We are proud to be part of the BARDA Accelerator Network, a comprehensive support system for health security innovators.
We leverage proprietary AI to accelerate and de-risk the way safer and more effective drugs are discovered and developed – benefiting biopharma companies and their investors. Our core service is the Operon™ platform, which simulates human biochemistry’s billions of interactions to understand the effects of exogenous compounds on healthy human biology.
GATC Health’s AI platform, Operon™, provides unparalleled insights, predicting clinical endpoints before trial design, and dramatically reducing costly late-stage failures. We’re trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners. We offer a powerful combination of multiomics, predictive analytics, and generative AI, ultimately bringing therapies to patients faster and more reliably.
Our platform empowers researchers and clinicians with unparalleled access to the intricate structure of biological samples, accelerating discovery in areas such as neuroscience, spatial anatomy, and drug development. We combine advanced imaging with sophisticated machine learning algorithms to deliver fast, reliable, and complete 3D analysis.
Founded in 2018, Translucence Biosystems is dedicated to advancing the field of biological imaging. We offer a comprehensive workflow, from tissue preparation to quantitative image analysis, enabling researchers to unlock new insights and drive innovation. We are committed to providing cutting-edge tools for the study of complex biological systems.
Our lead therapeutic candidate, PER-001, is a sustained-release intravitreal implant designed to release drug over six months, addressing the underlying pathology in ocular diseases driven by ischemia.
Perfuse’s team combines decades of experience in ocular drug discovery, development, and delivery, supported by a strong intellectual property portfolio and a syndicate of leading venture capital firms. We are committed to advancing innovative therapies to protect and improve the vision of patients with ocular diseases.
Sevgi Gurkan, MD, Founder and CEO, brings extensive experience from Merck and Rutgers, alongside Phillip Lai, MD, Chief Medical Officer, with a proven track record in ophthalmology clinical drug development.
We specialize in supporting clients from initial assay concept and biomarker discovery through clinical validation, regulatory approval, and GMP manufacturing. Our comprehensive suite of services includes biomarker discovery & validation, assay development (PCR, qPCR, ddPCR, NGS, Flow Cytometry), GxP and CLIA testing, and custom kit manufacturing.
ResearchDx’s commitment to quality is underscored by our ISO 13485:2016 certification, CLIA/CAP/ISO 15189 accreditation, and FDA registration. We partner with companies to accelerate the development and commercialization of innovative diagnostics, ultimately improving patient outcomes.
We develop and commercialize innovative, noninvasive diagnostic solutions leveraging our patented LTE-qMSP technology, which utilizes PCR and methylated DNA biomarkers to detect colorectal, bladder, and lung cancer with high sensitivity and specificity.
Our mission is to empower patients with actionable insights and affordable screening options, ultimately improving health outcomes. We are dedicated to providing accurate, accessible, and fast testing solutions for early cancer diagnosis, contributing to a healthier future for all.
Founded in 2019, Promis Diagnostics is committed to advancing cancer screening through rigorous research and development, evidenced by our publications and recognition within leading medical guidelines.
We utilize our proprietary technology platform – precisely engineered light – to stimulate physiological signals and initiate healing at the cellular level. Initially focused on an at-home treatment for COVID-19, EmitBio is now expanding its portfolio to redefine the standard of care for a range of respiratory conditions.
What sets EmitBio apart is our commitment to translating fundamental scientific discoveries into tangible medical solutions. Founded in 2020 and operating as a subsidiary of KNOW Bio, LLC, we combine deep expertise in light science with a strategic approach to developing and deploying innovative therapies. Our team, led by experienced leaders in biotechnology and medicine, is dedicated to transforming lives through the power of light.
We are a rapidly growing company with a strong foundation in intellectual property and a clear vision for the future of respiratory medicine.
We support a diverse range of clients, from biotechnology startups to established agricultural operations, addressing critical needs in areas such as PFAS analysis, pharmaceutical development, and regulatory compliance. Our mission is to deliver accurate, reliable, and timely data, empowering our clients to bring safe and innovative products to market.
Avazyme distinguishes itself through its ISO/IEC 17025:2017 accreditation, its early leadership in EPA Method 1633 PFAS testing, and a commitment to exceptional customer service, as evidenced by client testimonials highlighting our responsiveness and expertise. We are moving to a new location within the Research Triangle to accommodate our growth and continue providing superior service.
Our core services include food safety analyses, contaminant testing, feed additive petition (FAP) analysis, and a full spectrum of testing for product safety and quality related to Industrial Hemp, alongside specialized laboratory and "in-brewery" services for craft breweries and local hops growers and maltsters.
United Tissue Network supports innovation in patient care, utilizing human tissue to develop new products and improve healthcare outcomes. Our commitment to quality and safety is paramount, with rigorous testing and comprehensive donor histories ensuring the highest standards.
As an accredited, non-transplant anatomical tissue bank, we facilitate access to vital resources for education and research across the United States and internationally. We are proud to partner with facilities nationwide, providing a seamless and reliable supply of human tissue for critical medical advancements. Our services include turnkey partner facilities, tissue consulting, and a commitment to donor safety and ethical practices.
Our mission is to shift the focus from reactive treatment to preventative care, empowering both healthcare professionals and individuals with the tools to detect illness early and intervene effectively. We achieve this by combining cutting-edge research in areas such as glycemic health, infection detection, and risk factor discovery.
Through projects like DBDP, InfectionWatch, and Digital Health Equity initiatives, we are pioneering new approaches to disease prevention and personalized medicine. We are committed to advancing digital health solutions that benefit all individuals, regardless of demographics or access to technology. We combine expertise in data science, engineering, informatics, medicine, biological sciences, and population health to drive impactful change in the healthcare landscape.
We revolutionize medication safety by leveraging advanced data analysis and pharmacogenomics. Our core offering, the APPRAISE™ platform, analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a unique and comprehensive risk assessment, individualized down to the DNA.
GalenusRx addresses a critical public health challenge – adverse drug events – by offering a proactive, predictive, and preventive solution that optimizes drug regimens, reduces polypharmacy, and ultimately lowers healthcare costs. We partner with ACOs, payers, health systems, and pharmaceutical companies to deliver impactful results.
We offer a comprehensive suite of services, including clinical trials, patient recruitment, specimen collection and testing, and custom panel production. Our extensive Collection Network comprises certified drawing facilities, ensuring a diverse range of samples for research.
What sets BioCollections apart is our commitment to quality and our integrated technology platform, streamlining the entire testing cycle. We’ve successfully completed over 771 past research projects and currently support 120 ongoing initiatives, demonstrating our consistent reliability and expertise. COVID-19 testing and other specialized assays are also available.
We are dedicated to ‘One Transplant For Life’ to significantly improve both the longevity of the organ and the overall health and quality of life for transplant recipients so that a donor’s greatest gift will keep on giving.
Our lead compound, tegoprubart, an anti-CD40L antibody, offers a potentially transformative approach to managing immune responses in transplant patients, representing a significant advancement over existing treatment options. We are currently evaluating its potential in kidney, liver, and xenotransplantation.
Novus Therapeutics is committed to advancing the field of transplantation and improving patient outcomes through rigorous clinical development and scientific innovation.
We develop science-driven technologies targeting respiratory and ocular diseases, often stemming from compromised innate host defenses. Our pipeline, including ENAC, PULMONARY, and tPAD programs, addresses critical unmet needs in these areas.
Parion Sciences leverages a deep understanding of mucosal immunology and innovative formulation technologies to create novel therapies. We are dedicated to improving patient outcomes through targeted treatments for diseases like Primary Ciliary Dyskinesia and other respiratory conditions.
Founded in 2000, Parion Sciences has a strong track record of research and development, with a team of experienced scientists and a commitment to advancing patient care.
We leverage a patient-centric approach, combining innovative processes with strategic partnerships to expedite drug development and bring life-saving therapies to market faster.
Lamassu Biotech’s core expertise lies in genetically targeted therapies, exemplified by SA53, a novel treatment for locally advanced metastatic p53 wild-type tumors, currently in Phase 1/2a clinical trials at Cleveland Clinic, and RABI-767, a small molecule therapy for acute pancreatitis, undergoing Phase II clinical trials in partnership with Arrivo BioVentures.
Our commitment to collaboration with leading institutions like Mayo Clinic and The Ohio State University, coupled with a robust intellectual property portfolio, positions us at the forefront of medical innovation. Accelerating Hope and Healing
We develop and manufacture innovative microfluidic solutions, primarily focused on simplifying molecular workflows and making automation accessible to laboratories worldwide.
Our flagship product, the Redbud NA1 platform, utilizes patented Redbud Post technology to deliver rapid and reliable nucleic acid extraction, disrupting the sample prep market with its ease of use and small footprint.
Redbud Labs is committed to advancing diagnostics and genomic surveillance through cutting-edge microfluidics and a growing portfolio of patented technologies, including the MXR magnetic micro-posts and STR™ BeadPak chemistry. We are ISO 9001 and 45001 certified, ensuring the highest standards of quality and safety.
Since 1995, ZenBio has pioneered the use of adipose-derived stem cells (ASCs) and continues to innovate with a wide range of human cell systems, reagents, and custom services. We specialize in sourcing and isolating virtually any tissue type, offering researchers unparalleled access to high-quality, primary cells.
ZenBio distinguishes itself through its commitment to consistent quality, dedicated customer support, and a flexible approach to meeting the unique needs of each research partner. We are a trusted partner accelerating discovery and development across diverse applications, from drug discovery to cosmetic formulations. Our focus is on providing the highest quality human cell systems, reagents and contract services to our research partners, to develop and commercialize innovative research tools, leverage our expertise through research and development and strategic alliances, and accelerate discovery.
Our core technology, the NAB platform, combines the strengths of natural product screening – a historically rich source of new modes of action – with the unique properties of boron chemistry. This dual approach allows us to identify and deliver compounds with exceptional biological profiles and reduced environmental impact.
5Metis is led by a team of experienced scientists and business professionals, including Rich Gianni, MBA, and Brian Green, Ph.D., bringing decades of combined expertise in finance, research and development, and intellectual property management. We are dedicated to growing a better world through innovative agricultural solutions.
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | office@oerthbio.com | http://www.oerthbio.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@seegeneus.com | https://www.seegeneus.com/ | ||
Plano, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@stryderesearch.com | http://www.stryderesearch.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@merakris.com | http://www.merakris.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@zymtronix.com | http://www.zymtronix.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@plantresponse.com | http://www.plantresponse.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | contact@ramonaoptics.com | http://www.ramonaoptics.com | ||
Toledo, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@lexamed.com | http://www.lexamed.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@arkstone.ai | https://arkstone.ai | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@epicypher.com | http://www.epicypher.com | ||
Portland, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@medcure.org | http://medcure.org/ | ||
São Paulo, Brazil | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@igenomix.com.br | http://www.igenomix.com.br | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@nrichdx.com | http://www.nrichdx.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | contact@immunisbiomedical.com | http://www.immunisbiomedical.com | ||
Jersey City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@atombeat.com | https://www.atombeat.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@genecentric.com | http://www.genecentric.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | inquiries@curieco.com | https://www.curieco.com/ | ||
Plano, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | sales@phronetik.com | http://phronetik.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@thetraitscompany.com | https://www.thetraitscompany.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | contact@galaxydx.com | http://www.galaxydx.com | ||
Cambridge, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@terranabio.com | http://www.terranabio.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@ambrostx.com | http://ambrostherapeutics.com/ | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@aivitabiomedical.com | http://www.aivitabiomedical.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | isolereinfo@donaldson.com | https://www.isolerebio.com/ | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | admin@advan-bio.com | http://www.advan-bio.com | ||
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@proteanbiodx.com | http://www.proteanbiodx.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | customerservice@scitovation.com | http://www.scitovation.com | ||
St Petersburg, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | contact@ebi.bio | https://nabi.bio/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@juratatf.com | http://www.juratatf.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@cellmicrosystems.com | http://www.cellmicrosystems.com | ||
Fort Wayne, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@bw-fusion.com | http://www.biodyne-usa.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@somanta.com | http://www.somanta.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | contact@universitylabpartners.org | https://www.universitylabpartners.org/barda | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@gatchealth.com | https://www.gatchealth.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@translucencebio.com | http://www.translucencebio.com | ||
San Francisco, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@perfusetherapeutics.com | http://perfusetherapeutics.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@researchdx.com | http://www.researchdx.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@promisdx.com | http://www.promisdx.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@emitbio.com | http://www.emitbio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@avazyme.com | https://www.avazyme.com/ | ||
Phoenix, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | clientinfo@unitedtissue.org | http://www.unitedtissue.org/Medical_Device_Companies/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | bigideaslab@duke.edu | https://dunn.pratt.duke.edu/ | ||
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@galenusrx.com | http://www.galenusrx.com | ||
Miami, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | contact@biocollections.com | http://www.biocollections.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@eledon.com | http://novustherapeutics.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@parion.com | http://www.parion.com/ | ||
Cleveland, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@lamassubio.com | http://www.lamassubiotech.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@redbudlabs.com | https://redbudlabs.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@zen-bio.com | http://www.zen-bio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@5metis.com | http://www.5Metis.com |
50/545 results
Free Preview - Top 50 companies
Export Free JSON (50)
Frequently asked questions
FAQ updated November 2025
What is Enterprise League?
Enterprise League is a business platform built for the doers, small businesses and startups who want to get seen, get leads, and grow.We help you showcase your company, connect directly with potential clients and partners, and get valuable insights into your performance, all without the middlemen or the fluff. Whether you're a team of 2 or 200, Enterprise League puts you on equal ground with the big players.
How can my business benefit from joining Enterprise League?
You get visibility, leads, and control, all in one place. Joining Enterprise League puts your business in front of thousands of verified companies. List your services, connect with decision-makers, and see real-time data on who’s visiting your profile.It’s a streamlined way to grow your presence, build partnerships, and stop relying on outdated directories or cold outreach.
What are the key features of Enterprise League?
Enterprise League gives you tools to grow faster: • Custom Profiles:Boos your visibility with a standout business profile. • Smart search: Get found by clients looking for your exact services. • Real analytics: See who's visiting, what's working and where you rank. • Direct messaging: Skip the cold emails and chat direct with prospects. • Reviews insights: Showcase real reviews and let AI highlight what matters. • Zero-fee marketplace: List and find products or services for free.
How does the company verification process work?
Get verified for the price of a coffee $0 Verified companies appear higher in search, build trust faster, and unlock an extra features. One badge. More business.
Can I try Enterprise League for free?
Absolutely. Our Free Plan is built for small businesses. You get profile visibility, marketplace access, and business directory use, free. Want more reach and features? Upgrade when you’re ready. No pressure.
How does the Interactive Business Directory work?
It’s like Google, but only for serious businesses. Search by location, size, or sector. Visit company profiles, send a message, or download insights. It’s built for real B2B decisions, not noise.
How can I download business insights?
Need competitor or market data? We’ve got it, and yes, you can download it. With our Business Insights Download feature, you can export detailed company and industry data in CSV format, including decision-makers, background info, and more. It’s perfect for sales targeting, market research, or just getting smarter about your next move.
What is the Referral Program?
Invite a business friend. You both get rewarded. Refer another company and when they join, you both get 1 month of Premium — free. It’s our way of growing the community with good people.
How does the Reviews feature work?
Show off your best reviews, without lifting a finger. We pull your reviews from Google, Facebook, Trustpilot and more. Then our AI highlights the most important insights. You just sit back and shine.
What plans are available?
Three simple plans: Free Plan: Get started with a verified profile, search access, and marketplace listing. Premium: More reach, more leads, deeper analytics. Ultimate: All the bells and whistles, including a dedicated growth partner.
How can my company win an award?
We highlight the best of the best, and that could be you. We run 50+ startup award categories every year. Apply for free. Winners get recognition, visibility, and bragging rights.